HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
about
Activity of and effect of subcutaneous treatment with the broad-spectrum antiviral lectin griffithsin in two laboratory rodent modelsA Chimeric HIV-1 gp120 Fused with Vaccinia Virus 14K (A27) Protein as an HIV ImmunogenGlycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesNaturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmissionInvestigation of griffithsin's interactions with human cells confirms its outstanding safety and efficacy profile as a microbicide candidateInfluenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.Functional contributions of carbohydrate on AIDS virus glycoproteinRespiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2.Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycansAutoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.Utilizing the FIV model to understand dendritic cell dysfunction and the potential role of dendritic cell immunization in HIV infection.Genetic signatures in the envelope glycoproteins of HIV-1 that associate with broadly neutralizing antibodies.Dendritic cells transmit HIV-1 through human small intestinal mucosa.IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodesIL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infectionHuman metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activationHIV/SIV infection primes monocytes and dendritic cells for apoptosis.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Dysregulation of myelopoiesis by chronic alcohol administration during early SIV infection of rhesus macaquesFundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicityHIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cellsPartial enzymatic deglycosylation preserves the structure of cleaved recombinant HIV-1 envelope glycoprotein trimers.Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodiesOptimizing cellular immunity against HIV-1 Gag and preventing suppression by HIV-1 gp120.Binding of HIV-1 gp120 to DC-SIGN promotes ASK-1-dependent activation-induced apoptosis of human dendritic cells.Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.HIV-1 gp120 protein downregulates Nef induced IL-6 release in immature dentritic cells through interplay of DC-SIGNChimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cellsNovel immunomodulators from hard ticks selectively reprogramme human dendritic cell responses.An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cellsComparative Immunogenicity of Evolved V1V2-Deleted HIV-1 Envelope Glycoprotein TrimersAttenuated Listeria monocytogenes vectors overcome suppressive plasma factors during HIV infection to stimulate myeloid dendritic cells to promote adaptive immunity and reactivation of latent virus.HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.HIV-1-specific antibody responses during acute and chronic HIV-1 infectionHIV-1-induced impairment of dendritic cell cross talk with γδ T lymphocytes.Comparative glycoprofiling of HIV gp120 immunogens by capillary electrophoresis and MALDI mass spectrometry.How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?
P2860
Q24610025-DC8A93F6-9616-4ACA-8A1B-10428F9DA9A0Q27302081-B3661009-0BA7-4E63-92A0-44F8504B87A1Q28263932-7C5AAB92-22B9-4BFE-8BA8-98649FAD1066Q28727311-A61C5329-7680-4A00-9750-6A348227C07AQ28741890-2C172AC0-29D2-4D91-B9C6-32425978497DQ30387167-6EC2EDD1-F729-4BE1-962E-7FF120ED97EAQ30397572-1750F674-A025-49AC-AABD-D178648DD092Q30425776-41B81D0C-0FB9-4B99-BCAA-928CB8222E7FQ30432386-DF867E66-7C40-4D1C-A202-DCE204BBAFC4Q33601372-B3AFFD76-A8ED-42D4-865D-02ADE097F12CQ33653728-86AD80A3-BAAC-40A7-BFD0-BF943FB13CBFQ33719511-C20F2F15-3335-474F-B555-691076380C54Q33805304-EC2E0DCA-0426-408D-A8C9-6917F077F7DFQ33827771-82E6013E-CB29-4339-945A-138674CB28B4Q33869259-83EC25A7-C9B0-4CCA-868E-687261142968Q33882890-BE541248-960E-4EDE-8B29-F628EB5FD445Q33887805-8D9AE194-6DA7-4880-9C3D-5A04A45EE2DDQ33951949-14486429-D5A8-4322-A608-24A122ABBCB3Q33992829-1A59211E-F5B5-4EE8-BDEA-07BFC3C62B63Q34069519-2D83AB12-F09C-4146-9F1D-58A4514F5923Q34120130-E97D01CD-2076-48A2-B8E9-8E33BCD352F3Q34175370-7ECE7E14-8CF4-4C73-BB0B-0EC35B733B19Q34261887-59FEB8CB-D71C-47F6-AC6E-DCC06A82C682Q34285680-29E734A2-9A44-4637-9C15-89B0698593DAQ34392963-6E3FFA19-C836-4045-B73F-73D3531A219AQ34487151-01040F78-747F-4635-9895-AC8A39B38C82Q34574823-CABDEB1A-1868-4293-BFDD-1AA753207CBBQ34593647-4AE5F756-6B08-4C10-BF17-7451281C5557Q34648685-13D927CD-C57C-4520-B266-0EBFF9FDD0EEQ34658136-048C7015-FF8F-4C77-9E3F-DD12FEFA6C55Q34735203-F4207D31-0739-4D29-BAB6-91F197CDEB11Q34795446-14E173F4-36B2-44B8-8778-42ED1776DED0Q34796885-1EC81565-3A0A-4584-8504-1BD1D7DDCBC0Q34807480-40909CD1-14E5-43B1-A0C8-2D5F03EFDA4FQ34871958-9992B44D-E224-4AC1-B949-DB398554F971Q34952914-B18C8E9E-26D0-42CC-A7BA-9D5323EFB25EQ35096836-4B019EED-723B-49B7-B303-78126028324AQ35488947-2C0D8EB8-C90C-4208-8768-131859679A15Q35586908-1629267F-B74F-474E-AA36-2F0295BFDDC0Q35653703-D21CB5D4-2069-4DA2-8BBB-358C4CF133AA
P2860
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@ast
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@en
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@nl
type
label
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@ast
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@en
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@nl
prefLabel
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@ast
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@en
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@nl
P2093
P2860
P1433
P1476
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
@en
P2093
Antu K Dey
Dustin Charles
John P Moore
Kaustuv Banerjee
Lila Campbell-Gardener
Meimei Shan
Per Johan Klasse
Robert Dionisio
Rogier W Sanders
Sai Prasad N Iyer
P2860
P356
10.1371/JOURNAL.PPAT.0030169
P577
2007-11-01T00:00:00Z